Vet Med - Czech, 2015, 60(3):141-146 | DOI: 10.17221/8060-VETMED

Primary screening of potentially bio-active substances in the lyophilisate of Pectinatella magnifica biomassOriginal Paper

Z. Balounova1, V. Brezina2, K. Susterova1, J. Rajchard1
1 Faculty of Agriculture, University of South Bohemia, Ceske Budejovice, Czech Republic
2 Faculty of Medicine, Masaryk University, Brno, Czech Republic

The purpose of this research was to examine potential bio-active substances in the lyophilisate of Pectinatella magnifica biomass and its focus was on primary screening of the biomass. Extracts of lyophilisate were applied to murine cells and their effects on cell population growth, cell morphology and cell distribution were monitored. The inhibition of cytoskeleton repair reached its maximum after a 24-h exposure of the cells to the extract prepared at a temperature of 37 °C, whereas the 1-h application of the extract leached at a temperature of 37 °C resulted in quick repair of cytoskeletal function. When compared with the control, in which no extract was applied, the application of all treatments of the extract reduced the time needed for the duplication of cells. The lowest growth rate was found in the cells in the extract prepared at 37 °C for 24 h. The mitotic activity reached its maximum when using the extract prepared at 37 °C for 1 h. Under such conditions, the process of cell duplication was even faster than in the control sample, while it was the slowest using the extract prepared at 37 °C for 24 h. The study of potential biologically active substances of Pectinatella magnifica is highly topical due to the frequent occurrence of this organism in the water-supply and recreational reservoirs.

Keywords: bryozoan; cell line L929; spreading; specific growth rate; cell proliferation; time-lapse cinemicrography; bio-active substances

Published: March 31, 2015  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Balounova Z, Brezina V, Susterova K, Rajchard J. Primary screening of potentially bio-active substances in the lyophilisate of Pectinatella magnifica biomass. Vet Med-Czech. 2015;60(3):141-146. doi: 10.17221/8060-VETMED.
Download citation

References

  1. Ariza ME, Ramakrishnan R, Singh NP, Chauhan A, Nagarkatti PS, Nagarkatti M (2011): Bryostatin-1, a naturally occurring antineoplastic agent, Acts as a Toll-like receptor 4(TLR-4) ligand and induces unique cytokines and chemokines in dendritic cells. Journal of Biological Chemistry 286, 24-34. Go to original source... Go to PubMed...
  2. Balounova Z, Rajchard J, Svehla J, Smahel L (2011): The onset of invasion of bryozoan Pectinatella magnifica in South Bohemia (Czech Republic). Biologia 66, 1091-1096. Go to original source...
  3. Bastinec J (2009): Statistics, Operations Research, Stochastic processes (in Czech). FEKT VUT, Brno. 150 pp.
  4. CSN EN ISO 10 993-5 (2005): Biological evaluation of medical devices. Part 5: Test for in vitro cytotoxicity (in Czech). Cesky normalizacni institut, Prague.
  5. CSN EN ISO 17 025 (2005): Conformity assessment - General requirements for the competence of testing and calibration laboratories (in Czech). Cesky normalizacni institut, Prague.
  6. Davidson SK, Allen SW, Lim GE, Anderson CM, Haygood MG (2001): Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont "Candidatus Endobugula sertula" of the Bryozoan Bugula neritina. Applied Enviromental Microbiology 67, 4531-4537. Go to original source... Go to PubMed...
  7. Davidson SK, Haygood MK (1999): Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus endobugula sertula". Biological Bulletin 196, 273-280. Go to original source... Go to PubMed...
  8. Joo GJ, Ward AK, Ward GM (1992): Ecology of Pectinatella magnifica (Bryozoa) in an Alabama oxbow lake: colony growth and association with algae. Journal of the North American Benthological Society 11, 324-333. Go to original source...
  9. Lopanik N, Gufson KR, Lindquist N (2004): Structure of bryostatin 20: A symbiont-produced chemical. Defense for larvae of the host bryozoan, Bugula neritina. Journal of Natural Products 67, 1412-1414. Go to original source... Go to PubMed...
  10. Manning TJ, Land M, Rhodes E, Chamberlin L, Rudloe J, Phillips D, Lam TT, Purcell J, Cooper HJ, Emmett MR, Marshall AG (2005): Identifying bryostatins and potential precursors from the Bugula neritina. Natural Product Research 19, 467-491. Go to original source... Go to PubMed...
  11. Mayer AMS, Gustafson KR (2008): Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds. European Journal of Cancer 44, 2357-2387. Go to original source... Go to PubMed...
  12. Opravilova V (2005): Occurrence of two invertebrates species imported in Czech Republic Dugesia tirgina (Tricladida) a Pectinatella magnifica (Bryozoa) (in Czech). Sbornik Prirodovedeckeho klubu v Brne 2001-2005, 39-50.
  13. Paul VJ, Arthur K, Ritson-Williams R, Ross C, Kotty S (2007): Chemical defenses: From compounds to communities. Biological Bulletin 213, 226-251. Go to original source... Go to PubMed...
  14. Rodriguez S, Vergon JP (2002): Pectinatella magnifica Leidy 1851 (Phylactolaemates), a species of Bryozoa introduced in the north of Franche-Comte. Bulletin Francais de la Peche et de la Pisciculture 365-366, 281-296. Go to original source...
  15. Schmidt EW (2005): From chemical structure to environmental biosynthetic pathways: navigating marine invertebrate - bacteria associations. Trends in Biotechnology 23, 437-440. Go to original source... Go to PubMed...
  16. Sharp KH, Davidson SK, Haygood MG (2007): Localization of 'Candidatus Endobugulasertula' and the bryostatins throughout the lifecycle of the bryozoan Bugula neritina. ISME Journal 1, 693-702. Go to original source... Go to PubMed...
  17. Sun MK, Alkon DL (2006): Bryostatin-1: Pharmacology and therapeutic potential as a CNS drug. CNS Drug Reviews 12, 1-8. Go to original source... Go to PubMed...
  18. Zohar O, Lavy R, Zi XM, Nelson TJ, Hongpaisan J, Pick CG, Alkon DL (2011): PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiology of Disease 41, 329-337. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.